Lucid (LCID) results Q2 2025

Lucid (LCID) results Q2 2025

A Lucid Air electric vehicle (EV) at the company’s showroom in Tysons, Virginia, US, on Saturday, Feb. 17, 2024. Samuel Corum | Bloomberg | Getty Images Lucid Group on Tuesday softened its production outlook for the rest of the year as it reported second-quarter earnings that missed Wall Street expectations. The electric vehicle maker now…

Read More
Yum Brands (YUM) Q2 2025 earnings

Yum Brands (YUM) Q2 2025 earnings

Yum Brands on Tuesday reported quarterly earnings and revenue that missed analysts’ expectations as Pizza Hut and KFC reported U.S. same-store sales declines. Here’s what the company reported for the period ended June 30 compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Earnings per share: $1.44 adjusted vs. $1.46 expected Revenue:…

Read More
Alaska Airlines to launch London, Iceland flights, debut new livery

Alaska Airlines to launch London, Iceland flights, debut new livery

A sample of Alaska Airlines’ new livery for its Boeing 787-9 Dreamliners. Source: Alaska Airlines: Alaska Airlines is starting flights from Seattle to London and Reykjavik, Iceland, next May, adding to its global expansion following its acquisition of Hawaiian Airlines last year. Alaska plans to fly daily between Seattle and London’s Heathrow Airport on its Boeing 787-9…

Read More
Pfizer (PFE) Q2 2025 earnings report

Pfizer (PFE) Q2 2025 earnings report

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News | Getty Images Pfizer on Tuesday hiked its full-year adjusted profit guidance on its cost cuts and strong business performance this year. The company also reported second-quarter results that topped Wall Street’s estimates for the…

Read More
CVS Health (CVS) earnings report Q2 2025

CVS Health (CVS) earnings report Q2 2025

CVS Health on Thursday reported second-quarter earnings and revenue that topped estimates and raised its adjusted profit outlook, as it sees strength in its retail pharmacy business and some improvement in its insurance unit.  Shares of the retail drugstore chain jumped more than 1% on Thursday. The company now expects fiscal 2025 adjusted earnings of…

Read More
Eli Lilly’s Mounjaro shows similar heart health benefits as Trulicity

Eli Lilly’s Mounjaro shows similar heart health benefits as Trulicity

Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company’s older diabetes treatment, Trulicity. Mounjaro met the study’s main goal of showing that it wasn’t any worse than Trulicity at treating people with Type 2 diabetes and established cardiovascular disease. Eli Lilly…

Read More
Back To Top